ABSTRACT
INTRODUCTION

Non-syndromic cleft lip and palate (NS CLP)
is a complex congenital disability that affects 1/700 children worldwide. [1] [2] [3] Both genetic and environmental factors play a role in orofacial clefting, although most studies point to genetic factors as the major determinants. 4, 5 Few genetic variants have given rise to well-characterised molecular mechanisms in clefting pathogenesis. 3, 6 NS CLP can occur as part of more than 400 syndromes (syndromic CLP) or as an isolated malformation (non-syndromic CL/P). 7 Among the genetic factors, there is only one gene, Interferon Regulatory Factor (IRF6), has consistently been found to be associated with NS CLP in different populations. 8, 9 Single nucleotide polymorphisms (SNPs) in and around IRF6 have demonstrated a consistent association with NS CLP. 3, 6, 10 IRF6 is also the causative gene for Van der Woude syndrome (VWS) and Popliteal Pterygium Syndrome (PPS). 11, 12 The IRF6 gene maps to chromosome 1q22 consist of 9 exons and play a role in epidermal differentiation as mice deficient for IRF6 have a hyperproliferative epidermis that fails to undergo terminal differentiation. [13] [14] [15] [16] IRF6 regulates the switch between proliferation and differentiation, and loss of function mutation/polymorphism leads to incomplete fusion from palatal shelves due to failure of medial edge epithelium (MEE) differentiation. 17 Gene expression in CLP tissue from CLP patients has not been carried out much before, and this approach may potentially convey useful information on genes and families of genes interacting and playing a role in the different phenotypes in NS CLP populations. Many polymorphisms associated with NS CLP map to intragenic regions. The function of many of this polymorphisms is unknown, and their role is likely more complicated than coding mutations that can be predicted to damage or alter protein function. IFR6 rs2235373 is located in intron 7 (C/T) as the non-coding region, and we assumed that IRF6 noncoding polymorphisms also correlate with gene expression including mRNA expression.
In the DNA level, the physical position of rs2235373 is at g.20677 C > T, while in mRNA level, its location is at c.1060 + 37 C > T. 18 We examine the correlation between the genotypes (TT, CT and CC) of IRF6 rs2235373 and the level/ changes of mRNA expression as functional analysis in human oral epithelial from 198 individuals in Indonesia (136 individuals with NS CL/P consist of CU CLP (n = 42), CB CLP (n = 34), CLO (n = 33), CPO (n = 27) and 62 individuals as control 16 CPO and CLP seldom occur in the same families, CLO and CLP display different sex ratios and prevalence of associated malformations. 21, 22 However, there are also reasons why CLO might be distinct from CLP. Cleft lip has its origin as a malformation of the primary palate only, while CLP involves both the primary and secondary palates. 23, 24 Occasionally, a cleft lip can be found with a separated cleft of the soft but not the hard palate, which suggests two different defects.
12,23
CB CLP is considered to be the most severe form of CLP and studying expression based on phenotyping of CLP suppose to reveal previously unknown associations. 12 Rationalising that these epidemiological differences reflect differences in the underlying molecular processes, we compared the genotype and mRNA profiles/changes in oral epithelium removed by smear method with various type of phenotypes: CU CLP, CB CLP, CLO, CPO, and controls. This study was aimed to evaluate the effects of IRF6 rs2235373 polymorphism on mRNA expression changes in NS CLP with its phenotypes which include complete unilateral (CU) CLP, complete bilateral (CB) CLP, cleft lip only (CLO), and cleft palate only (CPO).
METHODS
This research was a cross-sectional laboratory analytical study. All participants were from Deutero Malay subrace as the majority of the race in Indonesia and only those individuals determined to have a non-syndromic form of CLP were included in this study. All of CLP patients were obtained based on the data from the Indonesian Cleft Lip and Palate Foundation (Yayasan Pembina Penderita Celah Bibir dan Langit-Langit (YPPCBL)) in Bandung, Indonesia. From all of the data, there was also more information about the history of environmental factors included such as the history of pregnancy, labour history, and birth weight, but we were only focusing on genetical factor, so environmental factors were excluded.
Identification as a non-syndromic form was just enough. In totally, all individuals including 198 individuals: 136 with NS CLP consist of CU CLP (n = 42), CB CLP (n = 34), CLO (n = 33), CPO (n = 27) and 62 as controls. This study was conducted in the Molecular Biology Laboratory of Health Research Unit of Faculty of Medicine Universitas Padjadjaran Bandung/Hasan Sadikin Hospital Bandung in May 2016-January 2017.
Genotyping was performed by isolating DNA isolation with informed consent from venous blood of each subjects using a DNA isolation kit from Pharmacia, then 200 ng of DNA template was used for Polymerase Chain Reaction (PCR) step. The PCR procedure was performed by using the primers of forward: 5'-CAGGGCTGCCGACTCTTCTA-3' and reverse: 5'-AGGAAAGCAGGAAGGTGAAAGA-3'. 25 The placement strategy for the primers for the gene segment and the location of IRF6 rs2235373 gene variant can be seen in Figure 1 . shown by black arrow 26 DNA sequencing covering IRF6 rs2235373 was performed by using the Sanger sequencing method. The sequencing process includes the whole segment showed in Figure 1 . From the sequencing result from whole samples, all nucleotide in those segment compared with normal nucleotide in gene bank by using sequence alignment program from BioEdit™. 26 The polymorphism is the form of substitution of base C into T to create 3 genotypes: TT (homozygous mutant genotype), CT (heterozygous genotype), and CC (normal genotype).
CAGGGCTGCCGACTCTTCTATGGGGACCTGGGTCCCATGCCTGACCAGGAGGAGCTCTTTGGTCCCGTCAG CCTGGAGCAGGTCAAATTCCCAGGTCCTGAGCATATTACCAATGAGAAGCAGAAGCTGTTCACTAGCAAGC TGCTGGACGTCATGGACAGAGGACTGATCCTGGAGGTCAGCGGTCATGCCATTTATGCCATCAGGCTGTGC CAGTGCAAGGTGTACTGGTCTGGGCCATGTGCCCCATCACTTGTTGCTCCCAACCTGATTGAGAGACAAAA GAAGGTCAAGCTATTTTGTCTGGAAACATTCCTTAGCGGTAAGTCATTTCTCAGAAAGTTGATCGTGGGAAT C A C T C T C T G G A A G T A C A T T C C T T C C A C T A T C C C T G T C T T T C A C C T T C C T G C T T T C C T
RT PCR detection of mRNA expression from IRF6 was performed through RNA isolation. After written informed consent was obtained from each individual, then epithelial cells were collected by smear method from palatal mucosa by 15 to 20 times of smear and stored in small tube consist of RNA later. Total RNA was extracted from those palatal epithelial by using Trizol® Reagent (Invitrogen, USA) and the concentration was measured by using nanodrop to ensure that there was RNA concentration obtained optimally.
The RNA was converted to cDNA by using oligo (dT) primer and Supercript® II (Invitrogen). Relative gene expression quantitation for IRF6, using GAPDH as an internal reference gene, was measured by real-time quantitative RT PCR based on the SYBR-Green method. The primers for IRF6 were 5'CGGCATAGCCCTCAACAAGAA-3'and 5'-TCCTTGGTGCCATCATACATCAG-3'; and for GAPDH were 5'-TGCTGAGTATGTCGTGGAG-3' and 5'-GTCTTCTGAGTGGCAGTGAT3', respectively.
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IRF6 mRNA expression change was analysed between genotypes (TT, CT to CT) from total NS CLP and controls, and also its phenotypes, by Livak method that was determined by using the comparative CT method (2 -ΔΔCt ) 27 and statistical analysis was performed by Kruskal Wallis test followed by Mann-Whitney test to compare groups with the p-value < 0.05 was considered statistically significant.
RESULTS
The genotyping results of the initial PCR product (showed DNA band of IRF6 rs2235373 gene segment with the size of 413 base pairs (bp)) and Sanger sequencing results are shown in Figure 2 . From all NS CLP phenotypes, the IRF6 mRNA expression of TT genotype from NS CU CLP showed the highest value, as it was 3.36 higher than control (Table 2) according to the Livak method, means that TT genotype expressed the IRF6 mRNA 3.6 times higher than the CC genotype, so there was the overexpression of IRF6 mRNA expression in TT genotype from NS CU CLP. On the other hand, the IRF6 mRNA expression of CT genotype from NS CB CLP showed the lowest value as it was 0.16 times lower than CC genotype (Table 3) according to the Livak method, so there was an underexpression of the IRF6 mRNA expression in CT genotype from NS CB CLP. Statistical analysis found that there was a significant difference of IRF6 mRNA between TT genotype and CC genotype from NS CU CLP and control (p = 0.008), and also between CT genotype and CC genotype from NS CB CLP and control (p = 0.000) ( Table 6 and Table 7 ). Lower mRNA expression (in the form of 2 -ΔΔCt ) of CT genotype compared with CC genotype from NS CB CLP that showed significant relationship can be seen in Figure 3 . 
DISCUSSION
IRF6 is one of the most important genes associated with CLP development. Formation of the lip and palate in human and mouse is a complex series of cellular processes during embryonic development. 28 Lip and palate are developed at different time points through common cellular processes that include proliferation, differentiation, and migration, thus it is essential to analysed IRF6 on the separate phenotype of CLP because there should be different role of IRF6 in forming lip and palate. 29 In this study, there were different results in mRNA level from each phenotype based on IRF6 rs2235373, and it means that IRF6 rs2235373 has an effect on transcription in such different manner in each NS CLP phenotype. It can be stated that IRF6 polymorphisms have a different role also in pathogenesis in CLP phenotype associated with proliferation, differentiation, and migration. However, the exact role of IRF6 in CLP pathogenesis was still cannot be elucidated.
Based on the previous study, normal craniofacial development involves the complex interaction of numerous genes, including transcription factors, growth factors, signalling molecules, and their respective receptors. IRF6 is one of the genes that direct the craniofacial processes to form, migrate, and fuse to form the face. Perturbation of this gene has the potential to alter normal craniofacial morphogenesis.
30,31,32
As a transcription factor, the role of IRF6 in the development of lip and palate is so important and form such complex interactions and pathways with other genes such as growth factor receptors, extracellular matrix components, and cell surface receptors, but the pattern of IRF6 interaction with other genes still cannot be explained yet.
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This study emphasised to evaluate the effect of IRF6 rs2235373 on mRNA expression changes in NS CLP with its phenotype because we considered that mRNA expression could be the first step to reveal IRF6 role in pathogenesis in NS CLP with its phenotype; thus we evaluated this gene through intron polymorphism of rs2235373.
However, before we discuss more the result, there were some reasons on why we chose oral epithelium as the sample for evaluating mRNA changes. Firstly, because IRF6 is the most important gene in epithelial proliferation. Based on previous research in animal models during the fetal period indicated that IRF6 regulates epitheliocytes proliferation, which has a key role in the formation of the oral periderm. Secondly, because IRF6 is strongly expressed in some areas in body parts, including oral epithelium.
Studies in an animal model had revealed that IRF6 was expressed in the facial primordium before and during morphogenesis of the primary palate, as it was expressed in the epithelium of the lateral and medial nasal prominences as well as the epithelium of the maxillary and mandibular prominences. 12, 29, 34 Preliminary findings in mice had also revealed the IRF6 expression in the MEE of fusing secondary palatal shelves, tooth buds, hair follicles, and skin. 34, 35 Also, IRF6 was strongly expressed in the MEE throughout palatal development. 29, 35 During the postnatal period, as in the adult, high IRF6 expression was also detected in hair follicles, palatal rugae, tooth germ and thyroglossal duct, external genitalia, and skin throughout the body. 11, 12, 25 In adult, IRF6 expression is still required in the proliferation and differentiation of keratinocyte and epidermis suprabasal layers. 15 Palatal development in the fetal period, and wound healing in the postnatal period/adulthood are both require epithelial compartment to migrate and proliferate thus we assumed that the functional role of IRF6 still can be detected from oral epithelium of adult/postnatal period based on IRF6 function in epidermal differentiation as a critical process of keratinocytes that responsible for building the functional epidermis. As IRF6 expressed strongly in oral epithelium, we took the sample from oral epithelium in the palatal region which considered to be keratinised based on the fundamental consideration that mRNA expression from NS CLP cases could be detected in the areas that are expressed (oral mucous region).
12
IRF6 rs2235373 also associates on NS CLP risk over some populations. 36 However, we did not analyse the polymorphism as the risk factor of NS CLP and its phenotype among Indonesian because analysing the polymorphism associated with mRNA expression changes will give more explanation on IRF6 functional role in NS CLP with its phenotype. Dissecting the role of IRF6 and the potential effects of polymorphisms required a comprehensive study regarding its expression pattern during embryonic development and how that pattern is regulated. It was shown that IRF6 is expressed in the epithelium of the lateral and medial nasal prominences as well as in the epithelium of the maxillary and mandibular prominences. Also, IRF6 was strongly expressed in the medial edge epithelium throughout palatal development. 29, 37 To understand the mechanistic basis of how polymorphism is associated with a particular phenotype, it is necessary to find out the polymorphism functionality (i.e., whether it alters the function of a gene or set of genes). In most cases, the role of an associated polymorphism is not defined and must be presumed as an effect on the gene that contains such polymorphism. Most common polymorphisms are potential regulatory polymorphisms located in noncoding regions, including promoter/upstream, downstream and intron regions, that may affect the transcription.
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Intron and untranslated regions transcribed as RNA that may affect transcription, RNA splicing, stability or translation, or in intergenic regions of unknown function.
38,39,40
A further level of regulation applies during splicing. This regulation may be altered when the splicing signals in the introns are mutated, where the splice factors bind. Mutations or polymorphisms in this region may lead to differentially spliced or truncated products that may not be functional or even more or less different functions. 40 The phenotype of intronic alterations may depend on how important is the affected protein or expression levels. IRF6 polymorphism of rs2235373 is in intron 7, which is a non-coding region, in the form of substitution of base C into T. This polymorphism may have influenced the splicing process. If the splicing process happens earlier or do not happen may cause the immature mRNA, so mRNA cannot exit from the cytoplasm.
IRF6 is predominantly present in the cytoplasm, but there is only very few information in the literature on how IRF6 rs2235373 polymorphism influences functional role in mRNA expression among NS CLP phenotypes. 41 The phenotypic features are a result of an imbalance between the proliferation and differentiation of precursor cells during development of ectodermderived structures. 42 The functional role of IRF6 polymorphism to be associated with NS CLP has not been yet defined thus our study evaluated IRF6 mRNA expression, not in embryonic development, but from the oral epithelium of NS CLP patients with its phenotype out of embryonic development phase. NS CLP phenotype will describe more about IRF6 function, whether this gene will also influence the severity of NS CLP.
As presented in Table 1 -5, there were under and overexpression of mRNA levels among all subjects, which include NS CLP with its phenotype and control. The more detailed result could not be seen in general of NS CLP (Table 1) . However, it was seen in NS CLP phenotype that includes NS CU CLP, NS CB CLP, NS CLO, and NS CPO. According to the Livak method analysis, the real mRNA overexpression can be found in NS CU CLP (Table 2) , and the real mRNA underexpression can be found in NS CB CLP (Table 3 ). In NS CU CLP (Table 2) , homozygous mutant of TT genotype expressed mRNA 3.36 times/being overexpressed than homozygous normal of CC genotype as control (p = 0.008), while in NS CB CLP (Table 3) , heterozygous mutant of CT genotype expressed mRNA was 0.16 lower and was an underexpression than homozygous normal of CC genotype as control (p = 0.000). These two results were contradictive. NS CB CLP is the most severe form of NS CLP, means that IRF6 mRNA underexpression may have a contribution to the severity of NS CLP.
There was a study revealed the effect of IRF6 rs642961 on mRNA expression changes in NS CLP which showed mRNA underexpression result, but IRF6 rs642961 is on promoter region. 25 There wasn't any previous study which also analyses IRF6 rs2235373 polymorphism associated with mRNA expression changes in other populations, so there were still no data to compare this finding. Based on the underlying theory as a result of some previous studies, the mechanism or how the pathogenesis of IRF6 mRNA expression could affect the NS CLP has not yet been defined. Based on the basic theory also, during early differentiation, ∆Np63 (p63 isoform) promotes transcriptional activation of IRF6, and the IRF6 protein, in turn, promotes ∆Np63 degradation. 42 This feedback regulation may play an essential role in controlling the proliferation and differentiation of keratinocytes.
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IRF6 expression is regulated through both SMAD and p38 MAPK pathways. In the absence of TGFβ receptor type II (TβRII), IRF6 expression decreases. ΔNp63 expression increases in the absence of TβRII resulting in reduced p21 gene (which encodes a cyclin-dependent kinase (CDK) inhibitor) expression in the palatal epithelium. Altered TGFβ-IRF6-ΔNp63-p21 activity results in the persistence of the MEE. 43 IRF6 is a mediator of TGFβ3 in the regulation of the EMT and apoptosis during palatal fusion. A schematic model outlines the TGFβ 3-IRF6-EMT-apoptosis pathways during palatal fusion. TGFβ3 upregulates the expression of IRF6 and enhances its nuclear translocation, which then seems to alter the expression of SNAI2 as epithelial mesenchymal transformation (EMT) regulator. Changes in SNAI2 expression represses Plakophilin, and ZO-1 (epithelial markers) expression and induces the EMT, which is essential to the process of palatal fusion.
Ectopic expression of IRF6 was able to rescue the Tgfβ3-blocked palatal fusion, and the SNAI2 knockdown then blocked this rescue effect. 41 Also, IRF6 has been reported to regulate ΔNp63 protein degradation, which will result in p21 expression induction and MEE apoptosis; this is also crucial to the palatal fusion process.12,41 IRF6 promotes the decay of ΔNp63, allowing keratinocytes to exit the cell cycle and differentiate. 42, 44 IRF6 induces downregulation of ΔNp63 in human keratinocytes as in the adult. The developmental defects were also observed in IRF6 of mutant mice was considered as the result from inability of IRF6 mutant cells to exit the cell cycle, leading to an undifferentiated hyperproliferative epidermis.
Thus, underexpression mRNA level in NS CBCLP in our study could alter the TGFβ-IRF6-ΔNp63-p21 activity results in the persistence of the MEE. On the other hand, mRNA expression that tends to increase or being overexpression by TT genotype in NS CU CLP could be caused by an alteration in the SNAI2 and TGFβ3 that leads to an altered ectopic expression of IRF6 to rescue the TGFβ3-blocked palatal fusion. Overexpression of IRF6 leads to hyperproliferation of epidermis that causes the failure of termination in cell differentiation.
However, such weaknesses still existed in this study. Other evaluation through another method, such as immunohistochemistry, was not carried out to compare mRNA expression result, and there was a limitation in the sample size. In the future study, we suggest that there should be comparison from mRNA expression in the embryonic development process in a larger sample size.
CONCLUSION
The IRF6 rs2235373 polymorphism of TT genotype tends to cause mRNA over expression in NS CU CLP and CT genotype tends to cause mRNA under expression in NS CB CLP. These results mean that this polymorphism influences the functional role of this gene, which is different in each NS CLP phenotypes. In this study, there is no influence from gender status because it has been considered that CLP is not linked to the sex chromosome.
